Found: 29
Select item for more details and to access through your institution.
Developing and validating a discrete-event simulation model of multiple myeloma disease outcomes and treatment pathways using a national clinical registry.
- Published in:
- PLoS ONE, 2024, v. 19, n. 8, p. 1, doi. 10.1371/journal.pone.0308812
- By:
- Publication type:
- Article
Variation in immunoglobulin use and impact on survival in myeloma.
- Published in:
- EJHaem, 2024, v. 5, n. 4, p. 690, doi. 10.1002/jha2.938
- By:
- Publication type:
- Article
Australians with chronic lymphocytic leukaemia continue to have high rates of second primary malignancies in the modern era.
- Published in:
- Internal Medicine Journal, 2024, v. 54, n. 7, p. 1223, doi. 10.1111/imj.16445
- By:
- Publication type:
- Article
The establishment of a multiple myeloma clinical registry in the Asia–Pacific region: The Asia–Pacific Myeloma and Related Diseases Registry (APAC MRDR).
- Published in:
- BMC Medical Research Methodology, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12874-024-02227-0
- By:
- Publication type:
- Article
Sickle cell disease in Australia: a snapshot from the Australian Haemoglobinopathy Registry.
- Published in:
- Internal Medicine Journal, 2024, v. 54, n. 5, p. 764, doi. 10.1111/imj.16297
- By:
- Publication type:
- Article
Real‐world outcomes in relapsed refractory multiple myeloma patients exposed to three or more prior treatments: an analysis from the ANZ myeloma and related diseases registry.
- Published in:
- Internal Medicine Journal, 2024, v. 54, n. 5, p. 773, doi. 10.1111/imj.16277
- By:
- Publication type:
- Article
Efficacy and Safety Analyses of Recombinant Factor VIIa in Severe Post-Partum Hemorrhage.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 9, p. 2656, doi. 10.3390/jcm13092656
- By:
- Publication type:
- Article
Poor outcomes for trial‐ineligible patients receiving polatuzumab for relapsed/refractory diffuse large B‐cell lymphoma in routine care: An Australian Lymphoma and Related Diseases Registry project.
- Published in:
- EJHaem, 2024, v. 5, n. 2, p. 325, doi. 10.1002/jha2.870
- By:
- Publication type:
- Article
The cancer nursing workforce in Australia: a national survey exploring determinants of job satisfaction.
- Published in:
- BMC Nursing, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12912-023-01629-7
- By:
- Publication type:
- Article
Red blood cell alloantibodies in the context of critical bleeding and massive transfusion.
- Published in:
- Blood Transfusion (17232007), 2023, v. 21, n. 5, p. 390, doi. 10.2450/2022.0131-22
- By:
- Publication type:
- Article
A sequential cohort study evaluating single‐agent KappaMab and KappaMab combined with lenalidomide and low‐dose dexamethasone in relapsed and/or refractory kappa light chain‐restricted multiple myeloma (AMaRC 01‐16).
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 4, p. 801, doi. 10.1111/bjh.18955
- By:
- Publication type:
- Article
The prognostic impact of t(11;14) in multiple myeloma: A real‐world analysis from the Australian Lymphoma Leukaemia Group (ALLG) and the Australian Myeloma and Related Diseases Registry (MRDR).
- Published in:
- EJHaem, 2023, v. 4, n. 3, p. 639, doi. 10.1002/jha2.742
- By:
- Publication type:
- Article
Clinical characteristics of Australian treatment‐naïve patients with classical Hodgkin lymphoma from the lymphoma and related diseases registry.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 4, p. 386, doi. 10.1111/ejh.13915
- By:
- Publication type:
- Article
The second revision of the International Staging System (R2‐ISS) stratifies progression‐free and overall survival in multiple myeloma: Real world data results in an Australian and New Zealand Population.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 2, p. e17, doi. 10.1111/bjh.18536
- By:
- Publication type:
- Article
Predictors of early mortality in multiple myeloma: Results from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR).
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 5, p. 830, doi. 10.1111/bjh.18324
- By:
- Publication type:
- Article
Māori and Pacific Peoples With Multiple Myeloma in New Zealand are Younger and Have Inferior Survival Compared to Other Ethnicities: A Study From the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 8, p. e762, doi. 10.1016/j.clml.2022.04.004
- By:
- Publication type:
- Article
P-116: The impact of SLiM criteria in myeloma in a real-life population: clinical characteristics, treatment and outcome from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S98, doi. 10.1016/S2152-2650(21)02243-6
- By:
- Publication type:
- Article
P-218: Tandem autologous + non-myeloablative allogeneic stem cell transplantation in relapsed multiple myeloma: an Australian joint report from the Alfred and Myeloma and Related Diseases Registry.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S159, doi. 10.1016/S2152-2650(21)02345-4
- By:
- Publication type:
- Article
NS-61: Higher EQ-5D-5L utility scores at diagnosis are associated with improved overall survival in Australian patients with multiple myeloma: results from the ANZ Myeloma and Related Diseases Registry.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S165, doi. 10.1016/S2152-2650(21)02355-7
- By:
- Publication type:
- Article
Receiving four or fewer cycles of therapy predicts poor survival in newly diagnosed transplant‐ineligible patients with myeloma who are treated with bortezomib‐based induction.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 4, p. 497, doi. 10.1111/ejh.13677
- By:
- Publication type:
- Article
906Can mammographic density add value to the Gail model in risk-stratifying women in BreastScreen Australia?
- Published in:
- International Journal of Epidemiology, 2021, v. 50, p. 1, doi. 10.1093/ije/dyab168.682
- By:
- Publication type:
- Article
The Myeloma Landscape in Australia and New Zealand: The First 8 Years of the Myeloma and Related Diseases Registry (MRDR).
- Published in:
- 2021
- By:
- Publication type:
- journal article
Pacific Islanders with multiple myeloma are younger and have inferior survival when compared to other ethnicities: a study from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e213, doi. 10.1016/j.clml.2019.09.354
- By:
- Publication type:
- Article
Receiving four or less cycles of therapy predicts poor survival in newly diagnosed transplant ineligible patients with myeloma who are treated with bortezomib-based induction.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e233, doi. 10.1016/j.clml.2019.09.388
- By:
- Publication type:
- Article
Renal Impairment at Diagnosis in Myeloma: Patient Characteristics, Treatment, and Impact on Outcomes. Results From the Australia and New Zealand Myeloma and Related Diseases Registry.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Prospective validation of the NCI Breast Cancer Risk Assessment Tool (Gail Model) on 40,000 Australian women.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Real-time tracking of cell cycle progression during CD8<sup>+</sup> effector and memory T-cell differentiation.
- Published in:
- Nature Communications, 2015, v. 6, n. 2, p. 6301, doi. 10.1038/ncomms7301
- By:
- Publication type:
- Article
Labour-Efficient In Vitro Lymphocyte Population Tracking and Fate Prediction Using Automation and Manual Review.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0083251
- By:
- Publication type:
- Article
Division-linked differentiation can account for CD8.
- Published in:
- European Journal of Immunology, 2009, v. 39, n. 1, p. 67, doi. 10.1002/eji.200838554
- By:
- Publication type:
- Article